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Systems approaches have been used to describe
molecular signatures driving immunity to influenza
vaccination in humans. Whether such signatures
are similar across multiple seasons and in diverse
populations is unknown. We applied systems ap-
proaches to study immune responses in young,
elderly, and diabetic subjects vaccinated with the
seasonal influenza vaccine across five consecutive
seasons. Signatures of innate immunity and plas-
mablasts correlated with and predicted influenza
antibody titers at 1 month after vaccination with
>80% accuracy across multiple seasons but were
not associated with the longevity of the response.
Baseline signatures of lymphocyte and monocyte
inflammation were positively and negatively corre-
lated, respectively, with antibody responses at
1 month. Finally, integrative analysis of microRNAs
and transcriptomic profiling revealed potential reg-
ulators of vaccine immunity. These results identify
shared vaccine-induced signatures across multi-
ple seasons and in diverse populations and might
help guide the development of next-generation
vaccines that provide persistent immunity against
influenza.1186 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier InINTRODUCTION
Seasonal influenza infection kills several hundred thousand peo-
ple every year, with the majority of deaths occurring among the
elderly (Pica and Palese, 2013; Simonsen et al., 2005). Although
vaccination is considered themost effective method for prevent-
ing influenza, it shows limited efficacy in the elderly (Sasaki et al.,
2011). The vaccine recommended for this age group is the
inactivated influenza vaccine that contains virus hemagglutinin
(HA) proteins from three (trivalent, TIV) or four of the circulating
influenza H1N1, H3N2, and B strains. The lower efficacy of the
influenza vaccine in elderly compared to young adults has
been associated with immunosenescence (Duraisingham et al.,
2013), such as impaired generation of antibody-secreting cells
(ASCs) (Sasaki et al., 2011) and memory CD8+ T cells (Wagar
et al., 2011) and CD4+ T cells (Kang et al., 2004). However, the
molecular mechanisms underlying the decreased vaccine effi-
cacy remain unexplored.
Systems vaccinology is an emerging field that applies systems
biology approaches and predictive modeling to vaccinology and
provides a powerful tool for unraveling the molecular mecha-
nisms of vaccine immunity (Pulendran, 2014; Pulendran et al.,
2010). Recently, systems vaccinology has been successfully
used to study the immune response to the influenza vaccine in
young adults (Bucasas et al., 2011; Cao et al., 2014; Franco
et al., 2013; Furman et al., 2013; Nakaya et al., 2011; Tsang
et al., 2014) as well as to other vaccines such as the yellow fever
(Gaucher et al., 2008; Querec et al., 2009) and meningococcusc.
(Li et al., 2013) vaccines. These studieswere able to identify gene
signatures (Nakaya et al., 2011), as well as cellular compositions
and gene modules (Furman et al., 2013), post-vaccination that
are predictive of the later antibody response vaccination. In addi-
tion, such approaches provided important insights into the path-
ways driving immune responses to vaccination (Oh et al., 2014;
Ravindran et al., 2014).
However, several fundamental issues in the field remain un-
addressed. First, there is still no comprehensive analysis of
the similarity of signatures to influenza vaccination across mul-
tiple seasons (Pica and Palese, 2013). This is a crucial issue
because the virus strains in the vaccine can change from
year to year and the impact of these variations on transcrip-
tional signatures is unknown. Second, there is limited informa-
tion about the gene regulatory networks and cellular responses
that underlie the sub-optimal immunity observed in the elderly
population. Third, because all previous studies have focused
on signatures that predict the antibody response at 4 weeks
after vaccination, the extent to which transcriptional signa-
tures are associated with the longevity of the antibody
response has not been examined. This analysis is important
for understanding how innate immunity can generate long-last-
ing antibody responses to influenza vaccination. Finally, little is
known about the role of microRNAs (miRNAs) in fine-tuning
the transcriptional responses of immune cells after influenza
vaccination.
To address these issues, we used systems vaccinology ap-
proaches to examine >400 young and elderly adults, including
diabetics, vaccinated with seasonal TIV during five consecutive
influenza seasons (2007–2011). These subjects included 212
individuals from our study and 218 individuals from a previously
published study (Franco et al. 2013). Our systems analysis iden-
tified universal signatures of immunity to vaccination spanning
multiple years in diverse human populations including the
young, elderly, and diabetic. Integrative analysis of microRNAs
and transcriptomic profiling revealed potential regulators of
vaccine immunity. These results can help guide the development
of next-generation vaccines that provide persistent immunity
against influenza.
RESULTS
Antibody Responses to Influenza Vaccination Correlate
with Age but Not Gender, Race, or Diabetic Status
We vaccinated with TIV a total of 212 subjects across 5 influenza
vaccine seasons from 2007 to 2011, among whom 54 were
elderly (>65 years old in 2010 and 2011 cohorts) (Figures S1A
and S1B). The 2011 cohort also included 17 subjects diagnosed
with type 2 diabetes (T2D). Overall, there was a 65:35 ratio of fe-
males to males, and the majority of subjects were of European
descent (Figure S1B). Blood samples were collected at baseline
(day of vaccination) and at the time points indicated (Figure 1A).
We performed microarray analyses on the peripheral blood
mononuclear cells (PBMCs) as indicated (Figure 1A). For the
2008 and 2009 seasons, we included in our analyses published
data from a previous study by Franco et al. (2013) containing
218 additional subjects. For a subset of the 2010 season cohort,
fluorescence-activated cell sorting (FACS) measurements as
well as miRNA profiling were also performed (Figure 1A). TheImmentire dataset is publicly available online at Immport (Bhatta-
charya et al., 2014) (http://immport.niaid.nih.gov/).
We evaluated the plasma antibody responses of all vacci-
nated individuals via hemagglutination-inhibition (HAI) antibody
titer assays. The individual antibody response for each of the
three influenza strains included in the vaccine was calculated
as the fold change between the HAI titer at day 28 relative to
the baseline titer. We then defined the magnitude of the HAI
response as the maximum fold change among the three influ-
enza strains (Figure 1B; Nakaya et al., 2011). Subjects were
classified as ‘‘high responders’’ if (1) their HAI response had
at least a 4-fold increase at 28 days (Sullivan et al., 2010) and
(2) the day 28 antibody titer was 1:40 or more for at least one
strain; subjects were classified as ‘‘low responders’’ otherwise.
In the 2010 and 2011 seasons, in which elderly subjects were
included, antibody responses showed a significant decrease
with age (Figures 1B, 1C, and S1C), consistent with previous
studies (Seidman et al., 2012). Vaccines from different seasons
induced varying levels of HAI responses, and there was a sig-
nificant decrease in the response with age (Figure 1C). Subjects
vaccinated during the 2010 season, the year after the H1N1
2009 pandemic, generated the strongest HAI responses. There
was no significant difference in antibody response based on
gender (Figure S1D), diabetic status (Figure S1E), or race
(data not shown). There was no significant difference in the
response between males and females in any of the seasons
examined (data not shown).
Gene Signatures of Antibody Responses acrossMultiple
Seasons in the Young and the Elderly
In order to identify transcriptional pathways associated with
the antibody response to vaccination, we performed gene set
enrichment analysis (GSEA) (Subramanian et al., 2005) on genes
correlated with the HAI response in each influenza season (Fig-
ure 2A). For this, we used a set of blood transcriptional modules
(BTMs) previously identified by our group through large-scale
network integration of publicly available human blood transcrip-
tomes (Li et al., 2014). BTMs related to the induction of inter-
ferons as well as the activation of dendritic cells (Figures 2A
and 2B) were enriched on days 1 and 3 after TIV vaccination,
whereas modules related to T cells at these time points were
negatively associated with the antibody response. These results
were validated by analysis of both seasons of the Franco et al.
(2013) dataset. On day 7, there was a robust enrichment of
ASC and cell cycle-related modules, consistent with our original
study (Nakaya et al., 2011).
Additionally, we compared transcriptional responses based
on gender, age, race, or diabetic status. We first performed dif-
ferential expression analysis between these groups (male versus
female, type-2-diabetes-positive versus -negative, and Euro-
pean versus African and/or Asian) using fold change expression
data from day 3 and day 7. There were very few differentially ex-
pressed genes based on gender (Figure S2A) or race (data not
shown), indicating similar responses after vaccination. Compar-
ison of gene expression between type-2-diabetes-positive and
-negative subjects revealed amodest number of differentially ex-
pressed genes (Figure S2B), but GSEA on genes ranked by cor-
relation with the day 28 HAI response in these two groups
showed a high degree of overlap in the modules associatedunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inc. 1187
Figure 1. Experimental Approach and Humoral Immunity to Influenza Vaccination in Young and Elderly
(A) Experimental approach used to study five consecutive influenza vaccination seasons. Microarray experiments and HAI assays were used to obtain the gene
expression profiles and antibody responses of 413 TIV vaccinees. Flow cytometry and miRNA expression data were obtained for vaccinees from 2010 season.
For 2008 and 2009 seasons, publicly available data (Franco et al., 2013) were included.
(B) HAI responses by season. ThemaximumHAI response (highest day 28-day 0 fold-induction among all three strains) is shown for all 212 subjects separated by
flu season, along with box plots indicating the first and third quartiles and median. For 2010 and 2011, subjects are also separated into young (<65 years old) and
elderly (65 or older). p values represent results of independent two-sample t test between responses of young and elderly.
(C) Correlation of HAI responses with age in the 2010 season and 2011 season. R and p represent the Pearson correlation coefficient and associated p value,
respectively.
See also Figure S1.with a high antibody response (Figure S2C). Based on the simi-
larity of these transcriptional responses, we decided not to
segregate subjects based on gender, race, or diabetic status
in subsequent analyses.
Given that we could identify pathways that consistently corre-
lated with the magnitude of HAI response (Figure 2A), we sought
to identify transcriptional signatures of immunogenicity across
multiple influenza seasons. In our previous study, we have
used DAMIP (discriminant analysis via mixed integer program-
ming) (Brooks and Lee, 2010) to find sets of 3–5 discriminatory
genes that could predict the antibody response of subjects
from the 2007–2009 seasons (Nakaya et al., 2011). Here we
applied DAMIP to a larger number of subjects across a greater
number of influenza vaccine seasons (Figure S3), as described
in the Experimental Procedures and Supplemental Experimental
Procedures. Here DAMIP was able to correctly predict the HAI
response in the blind testing group with 67.6%–70.0% accuracy
(Tables S1 and S2). Consistent with our previous work, the most
frequently selected genes included a large number of ASC genes
(Table S1).
Given the robustness of the module-level responses across
different TIV seasons, we wanted to investigate whether mod-
ule-level features were capable of accurately predicting vac-
cine-induced immunity in a multi-year dataset and in the elderly.
Therefore, we first generated BTM normalized enrichment1188 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inscores for each subject using single-sample GSEA (ssGSEA)
(Barbie et al., 2009) and then used these scores as inputs to an
artificial neural network classifier (Dreiseitl and Ohno-Machado,
2002) (see Supplemental Experimental Procedures for details). In
brief, the young subjects from all seasons were randomly divided
into training and testing groups in an 85%/15% ratio. For each
bootstrapping cycle, we split the young subjects (from all years)
as 85% (young training set) and 15% (young testing set) and put
all elderly aside (from both 2010 and 2011 years, the elderly
testing set). Then, we used the young training set to select the
features (in this case the BTMs) and to check their performance
in the same young training set. Next, we checked the perfor-
mance of these ‘‘predictive BTMs’’ in the young testing set and
elderly testing set. This process was repeated for 100 trials in or-
der to ensure that the performance was robust across many
random divisions of the data. For each of the 100 times that
this 85%/15% split in young subjects was done, we tested the
prediction on the same elderly testing set. With this approach,
we identified BTMs that predicted HAI responses in both the
young and elderly groups with accuracies ranging between
79.0% and 80.2% and between 64.7% and 72.3%, respectively,
using both day 3 and day 7 signatures (Figure 2C). Examination
of the modules most frequently selected by the algorithm in the
100 randomized trials revealed pathways related to innate im-
mune cell responses as well as leukocyte differentiation andc.
Figure 2. Signatures Associated with the Antibody Response Induced by TIV
(A) Heat map of blood transcription modules (BTMs, rows) and TIV seasons (columns) whose activity at days 1, 3, or 7 after vaccination is associated with HAI
response at day 28 after vaccination. Gene set enrichment analysis (GSEA, nominal p < 0.05; 1,000 permutations) was used to identify positive (red), negative
(blue), or no (gray) enrichment of BTMs (gene sets) within pre-ranked gene lists, where genes were ranked according to their correlation between expression and
HAI response. Seasons labeled in blue are from Franco et al. (2013) dataset. Modules shown are those consistently enriched in at least 70%of seasons on a given
day. Abbreviation is as follows: NES, normalized enrichment score.
(B) Genes in BTMM165; each ‘‘edge’’ (gray line) represents a coexpression relationship, as described in Li et al. (2014); colors represent the mean correlation for
seven TIV seasons between baseline-normalized gene expression at day 3 and HAI response at day 28 after vaccination.
(C and D) Identification of BTMs that predict antibody responses via neural network nalysis. Single sample GSEA (Barbie et al., 2009) enrichment scores were
generated for each BTM on day 3 and day 7 after vaccination in 85% of the young subjects (training set) and used as inputs to an artificial neural network classifier
to predict the day 28 antibody responses, in the remaining 15% of the young (young test set) or the elderly (elderly test set) subjects (see Supplemental
Experimental Procedures for details). The mean accuracies and standard deviations out of 100 randomized trials are shown, along with the frequency with which
each module was selected by the algorithm as an input to the classifier. In (C) ‘‘young’’ is <65 years and ‘‘elderly’’ >65 years and in (D) ‘‘young’’ is <40 years and
‘‘elderly >65 years.
See also Figures S2–S4.
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antigen presentation on day 3 and B cell/immunoglobulin pro-
duction and cell cycle pathways on day 7 (Table S3).
Interestingly, we observed similar classification accuracy in
both the young and elderly test sets when using the predictive
signatures trained on the young dataset (Figure 2C). This sug-
gests that although the elderly had lower antibody responses
to vaccination, the molecular signatures that were predictive of
high HAI response remained the same. One potential caveat to
this was that in the analysis in Figure 2C we had defined young
as <65 years and elderly as >65 years, a narrow chronological
distinction that could hamper quantitative analysis of age-related
effects. To address this issue, we performed additional analysis
by removing the intermediate-age subjects (between 40 and 65
years) from our analysis (Figure 2D). Thus here we defined young
as subjects younger than 40, and elderly as subjects older than
65. The results are similar to our original work (Figure 2C versus
Figure 2D). In addition, as the 2010 cohort has a sharper distinc-
tion between the young and the elderly (Figure S1A), we per-
formed GSEA on genes ranked by correlation with HAI response
(similar to the analysis of Figure 2A) for young and elderly sub-
jects in the 2010 cohort (Figure S4). There were a number of
consistently enriched modules in both the young and elderly, in
particular those relating to the interferon response and activation
of dendritic cells on day 1 and the plasmablast response on day
7. These results suggest that there were consistent transcrip-
tional signatures associated with the day 28 antibody response
in both groups. Together these results demonstrate that mod-
ule-level features are able to successfully predict vaccine immu-
nogenicity in TIV seasons in both young and elderly vaccinees.
Baseline Signatures Associated with Antibody
Responses
We also examined whether there were pre-vaccination tran-
scriptional signatures that were associated with antibody re-
sponses. Although there has been previous work aimed at iden-
tifying baseline cellular and molecular predictors of influenza
vaccine response (Frasca et al., 2010; Furman et al., 2013; Tsang
et al., 2014), these studies examined subjects within only a single
influenza season, and the robustness of these signatures in
predicting immunity to influenza vaccination acrossmultiple sea-
sons has not been determined. First, we performed GSEA (Sub-
ramanian et al., 2005) in each season by using genes ranked by
correlation between baseline expression and the HAI response.
However, this approach resulted in little overlap between sea-
sons, with no module consistently enriched in more than three
out of five seasons (Figure S5). This might have been due to a
reduced signal-to-noise ratio and increased batch effects owing
to the inability to use fold-change expression at baseline.
Although we attempted to adjust for batch effects in the day
0 expression data across seasons by using the ComBat software
(Johnson et al., 2007), these effects might have not been
completely removed.
To increase the power of this analysis so as to detect the more
subtle transcriptional signatures at baseline, we repeated the
procedure with all five seasons combined. In addition, publicly
available data from previously published influenza vaccine
studies by Franco et al. (2013) and Furman et al. (2013) were
included as independent validation sets (see Supplemental
Experimental Procedures for details). This approach revealed1190 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inseveral B-cell- and T-cell-related modules whose expression
pre-vaccination was positively correlated with an increased anti-
body response to vaccination in all studies (Figure 3A). In
contrast, modules related to monocytes were negatively corre-
lated with antibody responses (Figures 3B–3G). Interestingly,
contained within the monocyte-related modules were genes
such as TLR4, TLR8, NOD2, and ASGR2, which encode pro-
teins involved in innate sensing, and genes encoding IFN-gR,
IL-13R, TIMP2, LYN, SYK, and other molecules involved in
inflammation. This supports the concept that inflammatory re-
sponses at baseline might be detrimental to the induction of vac-
cine-induced antibody responses (Haq and McElhaney, 2014;
Pawelec et al., 2014). Investigation of the correlation with anti-
body response at a gene level (Figures 3B–3G) highlights the
strength of pathway-level analyses: although the module enrich-
ment was consistent across datasets, the individual genes
contributing to this enrichment varied from study to study.
Signatures Inducedby Vaccinationwith TIV in Youngand
Elderly
We next investigated the influence of age on the vaccine-
induced transcriptional signatures. To this end, we first identified
differentially expressed genes after vaccination in the young
versus elderly subjects from the 2010 season (Figure 4A) (in
which there is a sharp chronological separation between the
young and the elderly [Figure S1A]). By far the largest difference
in overall expression between the two groups occurred on day 1,
where the young exhibited a much greater number of both up-
and downregulated genes. Weighted correlation network anal-
ysis (WGCNA) (Langfelder and Horvath, 2008) was used to find
clusters of highly correlated genes among the TIV-regulated
genes in young (clusters Y1–Y6) and elderly (clusters E1–E5)
(Figure 4B). This method compares the correlation in expression
patterns among genes across all young or elderly subjects and
utilizes hierarchical clustering with dynamic tree cut to define
modules of genes that are temporally co-expressed within
each group. Genes in common to clusters Y4 and E3 were asso-
ciated with antibody-secreting cells (ASCs), whereas the overlap
between clusters Y1 and E1 contained several interferon-related
genes (Figure 4C). Although the genes shared by clusters from
young and elderly vaccinated individuals had similar temporal
expression profiles, the magnitude of the expression of inter-
feron-related genes differed, being higher in young individuals
(Figure 4C).
We then performed GSEA using genes ranked by their corre-
lation with age to identify modules with enriched expression in
either young or elderly vaccinees (Figure 4D). It is important to
note that in this analysis we used age as a quantitative variable,
rather than arbitrarily splitting the cohorts into young versus
elderly. In order to ensure the robustness of our results, we per-
formed this analysis separately on the two trials containing
elderly subjects (2010 and 2011) and identified modules that
were consistently enriched in both seasons. Natural killer (NK)
cell-related modules showed increased expression with age on
both day 3 and day 7 after vaccination, and several monocyte
modules showed increased expression with age on day 7. In
contrast, many B cell modules showed decreased expression
in older subjects on both day 3 and day 7. These results indicate
that elderly subjects might be mounting a significant innatec.
Figure 3. Baseline Signatures Are Associated with the Antibody Response
(A) Heat map of BTMs (rows) and TIV studies (columns) whose activity before vaccination is associated with HAI response at day 28 after vaccination. GSEA
(nominal p < 0.05; 1,000 permutations) was used to identify positive (red) or negative (blue) enrichment of BTMs (gene sets) within pre-ranked gene lists, where
genes were ranked according to their correlation between expression and HAI response. Circle size is proportional to the normalized enrichment score (NES).
Numbers in parentheses next to each study represent number of subjects in the study. Modules shown are those consistently enriched in at least three out of four
studies.
(B–G) Heat maps of genes within BTMs from (A); colors represent the mean correlation in each study between baseline gene expression and HAI response at day
28 after vaccination.
See also Figure S5.response, but that their adaptive B cell response is diminished.
One of the modules showing increased expression in the elderly
was BTM M61.0 (Figure 4E), which contains many killer cell
immunoglobulin-like receptor (KIR) and lectin-like receptor
(KLR) genes. These are inhibitory receptors that suppress the
cytotoxic activity of NK cells when bound to MHC I molecules
(KIRs) and cadherins and other ligands (KLRs) (Long et al., 2013).
Next, we examined whether or not any of the age-related tran-
scriptional differences were also associated with impaired anti-
body responses. By plotting the age-based enrichment score
of eachmodule against its antibody response-based enrichment
score on day 7, we were able to identify five modules whose
expression varied with age and were associated with either a
high or low antibody response (Figure 4F). Two B cell modules,
M47.0 and M69, showed increased expression in younger sub-Immjects and in subjects with high antibody responses, whereas
three monocyte- and myeloid-cell-related modules, S4, M4.3,
and M11.0, were enriched in the elderly and were also associ-
ated with a decreased antibody response in the 2010 and 2011
seasons. Interestingly, two of these modules, M11.0 and M4.3,
showed association with an increased antibody response in
the 2007 and 2008 seasons (Figure 2A), indicating that this asso-
ciation is not consistent across all five seasons on day 7. These
results demonstrate that TIV induces distinct but overlapping
transcriptional responses in the young versus elderly. The early
innate response at day 1, comprised of antiviral and type IFN-
related genes, seems to be impaired in the elderly. In contrast,
several transcriptional modules related to NK cells and mono-
cytes appear to have enhanced expression at baseline and after
vaccination, in the elderly relative to the young.unity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inc. 1191
Figure 4. Molecular Signatures Induced by Vaccination with TIV in Young Adults and in Elderly
(A) Number of genes differentially expressed (log2 fold-change > 0.2 and t test p value < 0.01) in young (<65 years) (left) and elderly (R65 years) (right) vaccinees on
days 1, 3, 7, and 14 after vaccination (2010 season).
(B) Heat map of highly correlated gene modules within the differentially expressed genes in (A) for young (rows, modules Y1–Y6) and elderly (columns, modules
E1–E5), generated by weighted correlation network analysis (Langfelder and Horvath, 2008). The number of genes in each module is shown in parentheses and
the number of genes in common between two modules is shown inside the squares. Colors represent the Fisher’s exact test p value of the overlap between
clusters. The 61 genes in common between Y4 and E3 are associated with ASCs.
(C) Temporal expression patterns of 197 interferon-related genes in common betweenmodules Y1 and E1 from (B). Black line represents the mean fold change of
all genes.
(D) BTMs (rows) whose activity at days 3 or 7 after vaccination (columns) is associated with the age of vaccinees from 2010 and 2011 seasons. GSEA (nominal p <
0.05; 1,000 permutations) was used to identify positive (red) or negative (blue) enrichment of BTMs (gene sets) within pre-ranked gene lists, where genes were
ranked according to their correlation between expression and increasing age. The intensity of the color and the size of the circles represent the normalized
enrichment score (NES) of GSEA. In this analysis we used age as a quantitative variable, rather than arbitrarily splitting the cohorts young versus elderly. Modules
shown are those consistently enriched in both seasons.
(E) Genes in BTMM61.0; each ‘‘edge’’ (gray line) represents a coexpression relationship, as described in Li et al. (2014); colors represent the correlation for 2010
season between baseline-normalized gene expression at day 3 after vaccination and the age of vaccinees.
(F) BTMs whose activity at day 7 after vaccination is correlated with the age of vaccinees (x axis) and/or is correlated with HAI response (y axis) in both 2010 and
2011 seasons. Values represent the mean of the NES obtained independently for each season. NES receives a value of zero if the BTM is not significantly
associated with age or HAI response (nominal p < 0.05; 1,000 permutations) in either season.
See also Figures S6 and S7.Cellular Responses Induced by Vaccination with TIV in
the Young and Elderly
The aforementioned transcriptional signatures of NK cells and
monocytes in the elderly subjects could have been caused by
de novo transcriptional induction of genes expressed in these
cell types or by changing representations of these cell types
within the PBMC compartment. In order to distinguish between
these two possibilities, we performed FACS analysis on PBMCs
in a subset of subjects from the 2010 cohort. Our analysis
showed that proportions of total NK cells in elderly subjects
were higher than those of young subjects at baseline as well as
at all the time points studied (days 0–14). Of note, vaccination
induced an increase in the percentage of NK cells in the elderly
subjects; in contrast, in the young there was a reduction in the
percentage of NK cells on day 1 after vaccination (Figure 5A).
Similar trendswere observed in the absolute numbers of NK cells
(data not shown). To examine this trend in the 2011 cohort,
where FACS data were unavailable, we used a deconvolution1192 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inmethod (Abbas et al., 2009; Gaujoux and Seoighe, 2013;
Shen-Orr and Gaujoux, 2013) to estimate cell frequencies based
on gene expression of amixed cell population. This approach re-
vealed increased estimated NK cell frequencies in the elderly on
day 3 after vaccination when compared to young, agreeing with
the 2010 FACS data (data not shown). These results confirm our
findings at a molecular level (Figure 4D) and show that the in-
crease in NK-cell-related expression in the elderly is due in
part to enhanced representation of this cell population after
vaccination.
We also explored the distribution of the NK compartment into
three subpopulations: CD56++ NK (CD56bright), CD56++CD16+
NK, and CD56dimCD16++ NK (Figure 5B). These NK cell subsets
have distinct functions: CD56dimCD16++ cells, the most abun-
dant population of NK cells in the blood, have significantly higher
cytotoxic activity, whereas CD56++ cells are characterized by
increased cytokine production and can exhibit immunoregula-
tory properties under certain conditions (Poli et al., 2009). Wec.
Figure 5. Flow Cytometry Analysis of
NK Cells in Young and Elderly after TIV
Vaccination
(A) Changes in total NK cell population after
vaccination represented as percent within all
PBMCs for young and elderly. Mean ± SEM.
(B) Blood NK cells were defined within the
CD3CD4CD19CD14 PBMCs. Dot blot re-
presents three distinct NK cell populations defined
by CD56 and CD16 markers: CD56++ NK,
CD56++CD16+ NK, and CD56dimCD16++ NK.
(C) Kinetics of magnitudes of CD56++ NK,
CD56++CD16+ NK, and CD56dimCD16++ NK cell
subsets in young (left) and elderly (right) after
vaccination. Mean ± SEM.
Areas under curve (AUC) in (A) and (C) were
calculated to compare magnitudes of total NK cells
and NK cells subsets between young and elderly
cohorts throughout the study duration (days 0–14)
and compared by t test. Changes of each of the NK
subset on the indicated time points after vaccina-
tion were compared to the day 0 (baseline) time
point by t test.
(D) Activation of each of the NK cell subsets were
assessed by CD69 staining and comparedwith day
0 (baseline) by t test. Data are represented as the
geometric mean fluorescence intensity (MFI) for
young (left) and elderly (right) at each time point,
mean ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.observed a higher frequency of CD56dimCD16++ cells coincident
with a lower frequency of CD56++ cells in the elderly at baseline,
consistent with previous studies (Figure 5C; Solana et al., 2014).
The distribution of these subpopulations was relatively stable
during the response, with CD56dimCD16++ cells showing a small
but significant increase in the elderly on day 1 after vaccination
and CD56++ cells increasing in the young on day 7. Additionally,
we examined the activation of these subsets through immuno-
staining for CD69, a marker associated with increased cytotox-
icity and IFN-g production (Figure 5D; Clausen et al., 2003;
Gorski et al., 2006). Elderly subjects showed increasing activa-
tion after vaccination in all three subsets, with highest expression
on day 3. In contrast, the young exhibited activation of the
CD56dimCD16++ subset as measured by CD69 expression only
on day 1 and at a lower level than in the elderly.
In addition to NK cells, we also observed higher proportions of
monocytes among the elderly at baseline and during the
entire duration of the study compared to young subjects (Fig-
ure S6A). In both groups, the percentage of total monocytes in
PBMCs increased substantially on day 1 after vaccination,
then returned to or below baseline levels. We further examined
the distribution of monocytes into three subsets: ‘‘classical’’
(CD14+CD16), ‘‘intermediate’’ (CD14+CD16+), and ‘‘non-clas-
sical’’ (CD14dimCD16++) (Figure S6B). The distribution of mono-
cyte subsets was similar in both groups, with the elderly having
a slight increase in intermediate monocytes compared to young
(Figure S6C). The activation of these subsets was also analyzed
by immunostaining for CCR5, a receptor for a number of inflam-
matory cytokines, and CD86, a costimulatory molecule involved
in T cell activation (Figure S6D). In both the young and elderly,
CCR5 expression peaked in classical and intermediate mono-Immcytes on day 1 after vaccination, corresponding with the inflam-
mation associated with the innate immune response. Elderly
subjects showed increased CCR5 expression in classical and in-
termediate monocytes compared to the young, whereas young
subjects had higher CD86 expression in these subsets. These re-
sults are consistent with the transcriptional changes observed
(Figure 4) and support the concept that persistent and excessive
inflammatory responses might be detrimental to the induction of
vaccine-induced antibody responses (Frasca et al., 2014; Haq
and McElhaney, 2014; Pawelec et al., 2014).
Molecular Signatures Associated with the Persistence
of Antibody Responses
A desirable feature of a good vaccine is the ability to induce long-
lasting protection from infection. To investigate how effectively
the influenza vaccine generates a long-lived response and iden-
tify the mechanisms responsible for this response, we measured
antibody titers in a subset of subjects at 180 days (D180) after
vaccination. The antibody responses peaked at day 28 (D28),
with a significant decline in most subjects by D180 (Figure 6A).
By applying the same criteria for seroconversion used for the
D28 high- versus low-responder classification to the D180
antibody responses, we saw that just over half of D28 high re-
sponders maintained their responder status on day 180 (‘‘persis-
tent’’ responders), whereas the remainder no longer met the
criteria for seroconversion on day 180 (‘‘temporary’’ responders).
Because the D180 antibody titer shows significant dependence
on the original antibody response generated on day 28 (Fig-
ure 6B), examining the molecular profile associated with the
D180 response would identify many of the mechanisms respon-
sible for generating the D28 response. In order to study theunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inc. 1193
Figure 6. Signatures Associated with the Persistence of TIV-Induced Antibody Response
(A) HAI response (fold change of HAI titer relative to baseline) through 180 days for temporary (n = 28) and persistent (n = 34) responders. Temporary responders
met the FDA criteria for seroconversion (minimum 1:40 titer and 4-fold increase after vaccination) on day 28 but not on day 180, whereas persistent responders
met the criteria on both days.
(B) Comparison between day 28 and day 180 HAI responses. Each symbol represents a single vaccinee and the color represents the season that they were
vaccinated (n = 62). Black lines represent the regression line (Pearson) for all vaccinees combined. Day 180/day 28 residual is computed as the (vertical) distance
from each sample to the regression line.
(C) Comparison between ‘‘S3 Plasma’’ BTM activity and the HAI responses at day 28 after vaccination. Each symbol represents a single vaccinee and the color
represents the season that they were vaccinated (n = 62). Black lines represent the regression line (Pearson) for all vaccinees combined.
(D) Comparison between ‘‘S3 Plasma’’ BTM activity and the HAI D180/D28 residual. Each symbol represents a single vaccinee and the color represents the
season that they were vaccinated (n = 62). Black lines represent the regression line (Pearson) for all vaccinees combined.
(E) Genes in BTMM51.0; each ‘‘edge’’ (gray line) represents a coexpression relationship, as described in Li et al. (2014); colors represent the correlation between
baseline-normalized gene expression at day 3 after vaccination and the D180/D28 residual.
(F) BTMs (bars) whose activity at day 7 after vaccination is significantly associated with the HAI D180/D28 residual (GSEA; nominal p < 0.05; 1,000 permutations).
Vaccinees from 2007 to 2010 seasons were combined. BTMs related to T cell functions (pink bars) or monocyte functions (purple bars) are shown.relative persistence of the response, we calculated residuals
from a linear fit between the D28 and D180 responses, thereby
removing the effect of the D28 response on the D180 response.
We observed that subjects with a higher D28 titer had a greater
decrease in HAI response between D28 and D180, indicating
increased difficulty to maintain higher levels of antibodies. The
linear fit therefore represents the expected D180 response given
a particular initial D28 response, and the residual can be consid-
ered an ‘‘adjusted’’ D180 response taking into account the orig-
inal D28 response. Subjects with positive residuals have a more
persistent response, whereas a negative residual represents a
waning response. As expected, correlation analysis of plasma-
blast module BTM S3 shows a positive association with the
D180 antibody response due to the effect of D28 antibody re-
sponses, generated through plasmablast expansion (Figure 6C).
However, when we performed correlation between the plasma-
blast module activity and the D180/D28 residual, we no longer
saw an association with the plasmablast expression (Figure 6D).
This result suggests that factors other than the expansion of
plasmablasts are responsible for maintaining a persistent anti-
body response.
To identify the pathways associated with a persistent or
waning response, we performed GSEA on genes correlated
with the D180 versus D28 residual. Among the BTMs most en-
riched in subjects with a persistent response on both days 31194 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inand 7 were several modules associated with cell movement
and adhesion, such as BTM 51 (Figure 6E). In fact, one of the
genes in module M51 that was highly correlated with the
response persistence was P-selectin (SELP), which plays an
important role in the adhesion and extravasation of leukocytes
out of the blood circulation and into organs or tissues (Wang
et al., 2007). In addition, the day 7 expression of a number of
T-cell-related modules was negatively associated with the
D180/D28 residual, indicating that increased T cell responses
might potentially result in more transient antibody responses
(Figure 6F). The plasmablast signature at day 7, which was pre-
dictive of the HAI titers at day 28, did not correlate with the D180/
D28 residual (Figure 6D).
Post-transcriptional Gene Regulation of the Immune
Response to Vaccination
MicroRNAs (miRNAs) have been identified as key regulators of
gene expression at a post-transcriptional level (Filipowicz
et al., 2008). Although there is some knowledge about miRNA
regulation of immune pathways (Lodish et al., 2008), their role
in responses to vaccination remains unaddressed. To assess
whether or not miRNAs contribute to the differences in response
we saw between young and elderly vaccinees, we measured the
miRNA expression profiles of 672 human miRNAs on days 1, 3,
and 7 after vaccination from a subset of subjects in the 2010c.
Figure 7. MicroRNA Expression Profiling of Young and Elderly TIV Vaccinees
(A) Heat map of miRNAs (rows) up- (red) or downregulated (blue) at days 1, 3, and 7 after vaccination in young and elderly (columns); paired t test (p < 0.05); total
number of differentially expressed miRNAs are shown at the bottom.
(B) MicroRNAs whose expression is positively or negatively correlated with HAI response in young and elderly; Pearson correlation (p < 0.05).
(C) Identification of networks potentially regulated by miRNAs. Activity of BTMs was determined by single-sample GSEA (Barbie et al., 2009) and correlated with
the expression of miRNAs. TargetScan database (Garcia et al., 2011) was used to identify the potential target genes of miRNAs.
(D) Heat map of BTMs (rows) whose activity at day 1 after vaccination correlated with the baseline-normalized expression of miRNAs (columns) at the same time
point. Positive and negative correlations are shown in red and blue, respectively.
(E) Genes in BTMM75; each gray line represents a coexpression relationship, as described in Li et al. (2014); each brown line connects a miRNA and its potential
target gene; each blue line represents a negative correlation (Pearson, p < 0.15) between the expression of miRNA and the expression of the potential target gene;
colors represent the mean correlation between baseline-normalized gene expression at day 1 and HAI response at day 28 after vaccination in the 2010 TIV
season.cohort (Figure 7A). We saw a significant difference in the miRNA
profiles between these two groups. Whereas a majority of the
differentially expressed miRNA in the elderly were upregulated
after vaccination, particularly on days 1 and 7, the young
exhibited predominantly downregulation of miRNA. We also
identified miRNA whose expression correlated with the day 28
antibody response (Figure 7B). We again saw differences be-
tween the young and elderly subjects, with the elderly having a
larger number of miRNA negatively correlating with the antibody
response when compared with the young. These results suggest
that miRNA might indeed be important regulators of the immune
response to influenza vaccination. miRNA expression reduces
the translation of its target genes through mRNA degradation
or silencing via the RNA-induced silencing complex, so the in-
crease in miRNA expression in the elderly after vaccination sug-
gests a possible mechanism for the impaired responses in this
population that merits further exploration.
To identify the miRNA that regulate particular immune path-
ways during vaccine response, we implemented a strategy to
integrate the mRNA andmiRNA omics-level measurements (Fig-
ure 7C). Because miRNA often have multiple related target
genes, we first generated normalized enrichment scores for
252 BTMs on a per subject basis by performing ssGSEA on
the transcriptomic data. We then performed correlation analysis
between all miRNA-BTM pairs, revealing groups of modules that
appear to be regulated together by several miRNA (Figure 7D) on
day 1 after vaccination.
Finally, we used the TargetScan miRNA database (Garcia
et al., 2011) to identify the genes in a given module predicted
to be targets of negatively correlating miRNAs. Of particular in-
terest was the regulation of module M75-antiviral interferonImmsignature (Figure 7E) on day 1 after vaccination, because the
interferon pathway plays a key role during the innate immune
response. This miRNA-mRNA network suggests potential novel
regulators of the interferon response after vaccination, such
as miR-424. This miRNA was predicted to target OAS3, a 20-
50-oligoadenylate synthase involved in viral RNA degradation
(Samuel, 2001), as well as CXCL10, an important chemokine
induced by IFN-g that serves as a chemoattractant for lympho-
cytes (Dufour et al., 2002).
DISCUSSION
In this paper we were able to identify shared and consistent mo-
lecular signatures of immunogenicity to TIV, across five influenza
vaccine seasons. At day 1 after vaccination, the pathways posi-
tively associated with the later antibody response revealed
a strong innate response marked by expression of interferons
and activation of dendritic cells. This response was also
observed on day 3, with enrichment of TLR signaling and antigen
presentation. By day 7, there was a strong signature from the
expansion of plasmablasts. Using the same modules in a single
sample approach as inputs to an artificial neural network classi-
fier allowed us to successfully predict antibody responses to
vaccination across all seasons included in our study. Using
pathway-level features as predictors of immune response is a
promising approach to not only reduce the variability in gene
expression across influenza seasons but also to provide
improved biological context to the predictive signatures.
In addition, we were able to establish baseline signatures
related to B and T cell expression that were associated with an
increased antibody response at day 28 after vaccination. Theseunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Inc. 1195
signatures were validated in two independent datasets, confirm-
ing that they are not specific to strain or study and are consistent
with previous findings that showed that the frequency of B cell
and T cell subsets at baseline was predictive of day 28 antibody
responses (Tsang et al., 2014). Therefore, the increased statisti-
cal power of our dataset allowed us to identify relatively weak
baseline transcriptional differences that were detectable only us-
ing flow cytometry in previous studies.
Our analysis of responses in young and elderly subjects re-
vealed important aspects about the relationship between
immunosenescence and vaccine response. We observed that
although the elderly exhibit diminished B cell responses after
vaccination, they also have enhanced NK cell and monocyte
numbers compared to young. Furthermore, the elderly displayed
increased frequency and activation of cytotoxic NK cells, as well
as increased CCR5 but diminished CD86 on proinflammatory
monocytes. Previous studies have shown that although the NK
cell population increases with age, there are concurrent changes
in the receptors of these cells, including decreases in the acti-
vating receptors NKp30 and NKp46 (Almeida-Oliveira et al.,
2011). NKp30 is involved in crosstalk with dendritic cells (Walzer
et al., 2005), and NKp46 has been shown to bind to influenza
hemagglutinin to allow NK-cell-mediated recognition of influ-
enza-virus-infected cells (Mandelboim et al., 2001), suggesting
potential mechanisms by which NK cells might regulate adaptive
immunity. Most importantly, monocytes were also increased
in the elderly before vaccination, and our baseline analysis
revealed a negative association between day 0 monocyte
expression and magnitude of antibody response. This indicates
a potential connection between the baseline state of the immune
system in the elderly and reduced responsiveness to vaccina-
tion. Together these results suggest potential mechanisms by
which changes to the innate response in the elderly might result
in diminished antibody responses to vaccination.
In addition, we also investigated the signatures associated
with the longevity of antibody responses. Although the goal of
all vaccines is to induce lasting immunity, waning immunity to
vaccination is a major issue in vaccinology (Pichichero, 2009).
Indeed, we observed a significant drop in antibody titers in a ma-
jority of subjects within 6 months of vaccination. By comparing
the relative persistence of the day 180 antibody responses
with BTM-normalized enrichment scores, we saw that the
expansion of plasmablasts, which plays an important role in
the development of the day 28 antibody response, had little ef-
fect on response longevity. Instead, we observed a potential
role for cell movement and adhesion in maintaining a persistent
antibody response. This transcriptional signature might be an in-
dicator of migration of plasmablasts into the bone marrow, a
crucial step in the generation of long-lived plasma cells (Rad-
bruch et al., 2006). This analysis demonstrates the role that initial
immune processes, as early as 3 days after vaccination, can
have in shaping the antibody response as much as 6 months
later.
Finally, we sought to explore how the previously examined
transcriptional responses to vaccination might be regulated, in
particular through the expression of miRNAs. miRNAs have
been shown to play an important role in modulating the signaling
pathways of the immune system (Lodish et al., 2008), but their
role in vaccine response has not been studied. By integrating1196 Immunity 43, 1186–1198, December 15, 2015 ª2015 Elsevier Intranscriptomic and miRNA expression data, we were able to
identify several potential miRNA regulators of the interferon
response after vaccination, such as miR-424. Previous studies
have shown that absence of regulation of interferon signaling
by miRNA can result in impaired CD8 T cell responses (Gracias
et al., 2013). These results demonstrate how the balance be-
tween positive and negative signals controlling the innate
response is necessary for a successful adaptive response and
underscore the importance of understanding the way in which
miRNAs help achieve this balance.
In summary, this longitudinal study across five influenza
seasons provided the opportunity to identify conserved mole-
cular elements present in immune response to TIV vaccina-
tion. Our pathway-level analyses revealed previously unknown
mechanisms that contribute to impaired responses to influenza
vaccination in the elderly. These systems approaches can help
delineate the molecular responses to vaccination in other immu-
nocompromised populations, such as infants and HIV-positive
individuals. They might also offer insights into the pathways by
which adjuvants improve vaccine response. By integrating this
knowledge, we will be able to provide a more complete picture
of how the immune system responds to vaccination and help
guide the development of the next generation of vaccines that
provide long-lasting immunogenicity and better protection of
at-risk populations.
EXPERIMENTAL PROCEDURES
Human Subjects and Specimen Collection
A total of 212 subjects were vaccinated with TIV during the 2007–2011 influ-
enza seasons. Written informed consent was obtained from each subject
with institutional review and approval from the Emory University Institutional
Review Board. Blood samples were collected at baseline and on days 3, 7,
28, and 180 days after vaccination. Peripheral blood mononuclear cells
(PBMCs) were isolated from fresh blood and stored in liquid nitrogen
(–210C). Detailed vaccination and sample collection procedures can be found
in the Supplemental Experimental Procedures. In general, the health of all
subjects was under control with no severe symptoms. Presence of relevant
co-morbidities was recorded and T2D patients did not have cancer, or major
infectious or autoimmune diseases, for at least 12 months prior to enrollment.
Diabetic individuals were 20 years or older and with an established diagnosis
of T2D for more than 6 months. Individuals had to be free of influenza and
of any symptoms associated with respiratory infections at the time of enroll-
ment. All T2D patients were under metformin treatment. Pregnancy and docu-
mented current substance and/or alcohol abuse were also exclusion criteria,
as well as use of medicines known to alter the immune response, such as
high-dose corticosteroids, within 6months prior to enrollment. As ‘‘co-morbid-
ities,’’ a few patients had hypertension, hyperlipidemia, pain (joint, back), or
hypothyroidism.
RNA Isolation and Microarray Analysis
Total RNA from PBMCs (1.53 106 cells) was purified using Trizol (Invitrogen,
Life Technologies Corporation) according to the manufacturer’s instructions.
Samples were checked for purity and hybridized on Human U133 Plus 2.0 Ar-
rays (Affymetrix). Microarray intensity data were normalized by RMA (Irizarry
et al., 2003) for each cohort separately. Pathway analyses were performed
using GSEA (Subramanian et al., 2005). In this 5-year analysis, we utilized a
multi-step DAMIP strategy as described in the Supplemental Experimental
Procedures (Figure S3). Classification rules or signatures associatedwith three
to five discriminatory genes were identified. We reported the classification
rules in which the predictive accuracies of HAI response in all other seasons
are at least 70%. This resulted in a total of 175 predictive rules, with accuracy
ranging between 80.0% and 87.3% (Table S1, Figure S3). For each of these
rules, a second layer of blind prediction was then performed on the remainingc.
blind test set (15% of subjects from each season) (Table S2). Detailed descrip-
tion of analyses can be found in the Supplemental Experimental Procedures.
Flow Cytometry Analysis
2–33 106 PBMCswere thawed and stained with live/deadmarker (Alexa Fluor
430, Life Technologies) to exclude dead cells. Cells were then stained with an
appropriate antibody cocktail. Cells were washed, fixed, and analyzed on the
LSRII flow cytometer (BD). All flow cytometry analysis was done with FlowJo
(Treestar). Blood NK cells were defined within the live singlets gate
CD3CD4CD19CD14 cells as the CD56++ NK, CD56++CD16+ NK, and
CD56dimCD16++ NK. The CD56++CD16+ subset is considered an intermediate
population in transition from the CD56++ to the CD56dimCD16++ subset (Be´ziat
et al., 2011). Monocytes were defined within the live singlet CD3CD19
PBMC as the CD14+CD16, CD14+CD16+, and CD14dimCD16++ monocytes.
The detailed staining procedures and list of antibodies are presented in the
Supplemental Experimental Procedures.
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